SARS CoV 2 Vaccines, Bivalent
retiredURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.10002Copied!
Version20221206Copied!
PublisherClinical ArchitectureDate2023-06-21T18:16:37-04:00Purpose(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)
Expansion
| Code | Display | System |
|---|---|---|
| 229 | http://hl7.org/fhir/sid/cvx | |
| 300 | http://hl7.org/fhir/sid/cvx | |
| 301 | http://hl7.org/fhir/sid/cvx |
systemhttp://hl7.org/fhir/sid/cvx
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://hl7.org/fhir/sid/cvx",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 3
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2023-06-21T18:16:37-04:00",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "Clinical Architecture",
"jurisdiction" : [ {
"coding" : [ {
"system" : "urn:iso:std:iso:3166",
"code" : "US"
} ]
} ],
"purpose" : "(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)",
"name" : "SARSCoV2VaccinesBivalent",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "229",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "300",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "301",
"display" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation",
"version" : "20240315"
} ],
"total" : 3,
"identifier" : "urn:uuid:292bf2b1-c2cd-45f3-ad2b-558c2fec450c",
"timestamp" : "2024-06-14T16:07:12-04:00"
},
"title" : "SARS CoV 2 Vaccines, Bivalent",
"extension" : [ {
"valueString" : "Clinical Architecture",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2023-06-21",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2022-12-06",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "retired",
"id" : "2.16.840.1.113883.3.3616.200.110.102.10002",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.10002",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.3616.200.110.102.10002"
} ],
"version" : "20221206"
}